Qualigen Therapeutics Inc (QLGN)
0.2996
-0.01
(-3.01%)
USD |
NASDAQ |
Apr 25, 16:00
0.2996
0.00 (0.00%)
After-Hours: 16:35
Qualigen Therapeutics Shareholders Equity (Quarterly): -2.104M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.104M |
| September 30, 2023 | -1.641M |
| June 30, 2023 | 2.034M |
| March 31, 2023 | 4.869M |
| December 31, 2022 | 7.236M |
| September 30, 2022 | 12.15M |
| June 30, 2022 | 14.47M |
| Date | Value |
|---|---|
| March 31, 2022 | 13.52M |
| December 31, 2021 | 16.56M |
| September 30, 2021 | 10.85M |
| June 30, 2021 | 12.26M |
| March 31, 2021 | 16.23M |
| September 30, 2020 | -2.889M |
| June 30, 2020 | -13.15M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-13.15M
Minimum
Jun 2020
16.56M
Maximum
Dec 2021
6.457M
Average
9.041M
Median
Shareholders Equity (Quarterly) Benchmarks
| Marizyme Inc | -21.95M |
| CEL-SCI Corp | 12.65M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 3.314M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.033M |
| Total Liabilities (Quarterly) | 4.137M |